Single-stranded DNA linking composition

JPWO2024248166A1Pending Publication Date: 2024-12-05
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2025524931
Authority / Receiving Office
JP · JP
Patent Type
Applications
Priority Date
2023-05-30
Filing Date
2024-04-02
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

Current methods for single-stranded DNA ligation are inefficient and limited, particularly in applications requiring sequencing of damaged or degraded DNA, such as ancient DNA and cell-free DNA, where most library preparation kits are designed for double-stranded DNA and require the use of ribotails that can be disadvantageous in certain technologies.

Method used

A single-stranded DNA ligation composition and kit utilizing a protein with an amino acid sequence having high identity to SEQ ID NO: 2 or 4, which exhibits strong single-stranded DNA binding activity, allowing for efficient ligation of single-stranded DNA without the need for ribotails, and includes PEG for enhanced activity.

Benefits of technology

Enables highly efficient sequencing library preparation from single-stranded DNA sources, including degraded DNA, without the limitations of ribotail-dependent methods, and allows for bisulfite treatment, improving DNA methylation analysis and library yield.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

Provided are: a novel enzyme composition having an efficient single-stranded DNA linking activity; and others. The present invention pertains to: a single-stranded DNA linking composition which is used for linking single-stranded DNA that serves as at least one acceptor to single-stranded DNA that serves as at least one donor, the composition containing (a) a protein comprising the amino acid sequence represented by SEQ ID NO:2 or SEQ ID NO:4 and / or (b) a protein comprising an amino acid sequence having 70% or higher identity with the amino acid sequence represented by SEQ ID NO:2 or SEQ ID NO:4 and having a single-stranded DNA linking activity; and others.
Need to check novelty before this filing date? Find Prior Art

Description

Single-stranded DNA ligation composition

[0001] The present invention relates to a composition for ligating single-stranded DNA, a single-stranded DNA ligation agent, a single-stranded DNA ligation kit, etc., which are used to ligate a single-stranded DNA as an acceptor and a single-stranded DNA as a donor.

[0002] Enzymes with potent single-stranded DNA (ssDNA) ligation activity would be expected to have many applications, but no such enzymes are currently known. However, the high demand for single-stranded DNA ligation technology is easily understood when considering sequencing library preparation. Recently, various types of single-stranded DNA have attracted attention, and efficient sequencing of them is desired. For example, it has been revealed that short single-stranded DNA contained in cell-free fractions of blood has characteristics different from nucleosome-sized cell-free DNA (cfDNA), and its analysis is expected to be useful (see Non-Patent Documents 1-3). Furthermore, DNA extracted from bones excavated from ruins thousands of years ago is generally significantly degraded and damaged, resulting in a single strand (see Non-Patent Document 4). There are likely many other examples of single-stranded DNA that require sequencing. However, most currently available library preparation kits are compatible only with double-stranded DNA, and only a limited number are compatible with single-stranded DNA. Even those compatible with single-stranded DNA and their protocols are not particularly practical in terms of library preparation efficiency (see Non-Patent Documents 1, 5, and 6).

[0003] To overcome this lack of a highly efficient method for ligating single-stranded DNAs, the present inventors recently developed a technique called TACS ligation (see Non-Patent Document 7). In this method, terminal deoxynucleotidyl transferase (TdT) is first used to add several adenylate residues to the 3' end of the target single-stranded DNA (see Non-Patent Document 8). This short RNA stretch (ribotail) serves as an excellent substrate for RNA ligase and acts as a connector that enhances its ligation activity (see Non-Patent Document 9). As a result, the single-stranded DNA ligation activity of RNA ligase in the presence of TdT exceeds 80% under optimal conditions (see Non-Patent Document 7). Using this TACS ligation principle, its high single-stranded DNA ligation activity enables highly efficient sequencing library preparation from cell-free DNA in blood (see Non-Patent Document 1) and highly degraded DNA extracted from ancient human bones. However, the ribotails introduced during this process have the limitation that they cannot be used in the development of technologies where base insertion or the presence of RNA is a disadvantage. Prior art documents

[0004] Non - patent literature: Hisano, O., Ito, T. and Miura, F. (2021) Short single - stranded DNAs with putative non - canonical structures comprise a new class of plasma cell - free DNA. BMC Biol, 19, 225. Cheng, J., Morselli, M., Huang, W. - L., Heo, Y. J., Pinheiro - Ferreira, T., Li, F., Wei, F., Chia, D., Kim, Y., He, H. - J. et al. (2022) Plasma contains ultrasmall single - stranded DNA in addition to nucleosomal cell - free DNA. iScience, 25, 104554. Hudecova, I., Smith, C. G., Hansel - Hertsche, R., Chilamakuri, C. S., Morris, J. A., Vijayaraghavan, A., Heider, K., Chandrananda, D., Cooper, W. N., Gale, D. et al. (2022) Characteristics, origin, and potential for cancer diagnostics of ultrasmall plasma cell - free DNA. Genome research, 32, 215 - 227. Meyer, M., Kircher, M., Gansauge, M. T., Li, H., Racimo, F., Mallick, S., Schraiber, J. G., Jay, F., Prüfer, K., de Filippo, C. et al. (2012) A high - coverage genome sequence from an archaic Denisovan individual. Science, 338, 222 - 226. Gansauge, M. T. and Meyer, M. (2013) Single - stranded DNA library preparation for the sequencing of ancient or damaged DNA. Nature protocols, 8(4),737−748.Gansauge,M.T.,Gerber,T.,Glocke,I.,Korlevic,P.,Lippik,L.,Nagel,S.,Riehl,L.M.,Schmidt,A.and Meyer,M.(2017)Single−stranded DNA library preparation from highly degraded DNA using T4 DNA ligase.Nucleic acids research,45(10),e79.Miura,F.,Shibata,Y.,Miura,M.,Sangatsuda,Y.,Hisano,O.,Araki,H.and Ito,T.(2019)Highly efficient single−stranded DNA ligation technique improves low−input whole−genome bisulfite sequencing by post−bisulfite adaptor tagging.Nucleic acids research,47(15),e85.Schmidt,W.M.and Mueller,M.W.(1996)Controlled ribonucleotide tailing of cDNA ends(CRTC)by terminal deoxynucleotidyl transferase:a new approach in PCR−mediated analysis of mRNA sequences.Nucleic acids research,24,1789−1791.Blondal,T.,Thorisdottir,A.,Unnsteinsdottir,U.,Hjorleifsdottir,S.,Aevarsson,A.,Ernstsson,S.,Fridjonsson,O.H.,Skirnisdottir,S.,Wheat,J.O.,Hermannsdottir,A.G.et al.(2005)Isolation and characterization of a thermostable RNA ligase 1 from a Thermus scotoductus bacteriophage TS2126 with good single−stranded DNA ligation properties.Nucleic acids research,33,135−142.Zhang,X.H.and Chiang,V.L.(1996)Single−stranded DNA ligation by T4 RNA ligase for PCR cloning of 5′−noncoding fragments and coding sequence of a specific gene.Nucleic acids research,24,990−991.Tessier,D.C.,Brousseau,R.and Vernet,T.(1986)Ligation of single−stranded oligodeoxyribonucleotides by T4 RNA ligase.Anal Biochem,158,171−178.Blondal,T.,Hjorleifsdottir,S.H.,Fridjonsson,O.F.,Aevarsson,A.,Skirnisdottir,S.,Hermannsdottir,A.G.,Hreggvidsson,G.O.,Smith,A.V.and Kristjansson,J.K.(2003)Discovery and characterization of a thermostable bacteriophage RNA ligase homologous to T4 RNA ligase 1.Nucleic acids research,31,7247−7254.Zhelkovsky,A.M.and McReynolds,L. A. (2012) Structure-function analysis of Methanobacterium thermoautotrophicum RNA ligase-engineering a thermostable ATP independent enzyme. BMC Mol Biol, 13, 24. Miura F. et al. , Nucleic Acids Res. 2012, 40, e136 Miura F, Kawaguchi N, Yoshida M, Uematsu C, Kito K, Sakaki Y, Ito T. Absolute quantification of the budding yeast transcriptome by means of competitive PCR between genomic and complementary DNAs. BMC Genomics. 2008;9:574. Miura F, et al. , A highly efficient scheme for library preparation from single-stranded DNA, Scientific Reports, 13, 13913, 2023,

[0005] Under these circumstances, there has been a demand for the development of novel enzyme compositions and the like that have efficient single-stranded DNA ligation activity without the addition of ribotails.

[0006] The present invention has been made in consideration of the above circumstances, and provides a composition for ligating single-stranded DNA, a single-stranded DNA ligation agent, a kit for ligating single-stranded DNA, and the like, as shown below.

[0007] [1] A composition for ligating single-stranded DNAs used to ligate one or more types of single-stranded DNA as acceptors and one or more types of single-stranded DNA as donors, the composition comprising: (a) a protein comprising the amino acid sequence set forth in SEQ ID NO: 2 or 4, and / or (b) a protein comprising an amino acid sequence having 70% or more identity to the amino acid sequence set forth in SEQ ID NO: 2 or 4, and having single-stranded DNA ligation activity. [2] The composition according to [1] above, wherein the acceptor DNA has a base length of 12 or more and / or the donor DNA has a base length of 10 or more. [3] The composition according to [1] above, further comprising PEG.

[0008] [4] A single-stranded DNA ligation agent used to ligate one or more types of single-stranded DNA as acceptors and one or more types of single-stranded DNA as donors, the ligation agent comprising: (a) a protein comprising the amino acid sequence shown in SEQ ID NO: 2 or 4, and / or (b) a protein comprising an amino acid sequence having 70% or more identity to the amino acid sequence shown in SEQ ID NO: 2 or 4, and having single-stranded DNA ligation activity. [5] The ligation agent according to [4], wherein the acceptor DNA has a base length of 12 or more and / or the donor DNA has a base length of 10 or more. [6] The ligation agent according to [4], further comprising PEG.

[0009] [7] A single-stranded DNA ligation kit used to ligate one or more types of single-stranded DNA as acceptors with one or more types of single-stranded DNA as donors, the kit comprising: (a) a protein comprising the amino acid sequence shown in SEQ ID NO: 2 or 4, and / or (b) a protein comprising an amino acid sequence having 70% or more identity to the amino acid sequence shown in SEQ ID NO: 2 or 4 and having single-stranded DNA ligation activity. [8] The kit according to [7] above, wherein the acceptor DNA has a base length of 12 or more and / or the donor DNA has a base length of 10 or more. [9] The kit according to [7] above, further comprising PEG.

[0010]

[10] A method for producing ligated single-stranded DNAs, comprising contacting one or more types of single-stranded DNA as acceptors and one or more types of single-stranded DNA as donors with (a) a protein comprising the amino acid sequence of SEQ ID NO: 2 or 4, and / or (b) a protein comprising an amino acid sequence having 70% or more identity to the amino acid sequence of SEQ ID NO: 2 or 4 and having single-stranded DNA ligation activity, thereby ligating the acceptor DNAs and the donor DNAs.

[11] A method for ligating single-stranded DNAs, comprising contacting one or more types of single-stranded DNA as acceptors and one or more types of single-stranded DNA as donors with (a) a protein comprising the amino acid sequence of SEQ ID NO: 2 or 4, and / or (b) a protein comprising an amino acid sequence having 70% or more identity to the amino acid sequence of SEQ ID NO: 2 or 4 and having single-stranded DNA ligation activity, thereby ligating the acceptor DNAs and the donor DNAs.

[0011]

[12] The method according to

[10] or

[11] above, wherein the acceptor DNA has a base length of 12 or more and / or the donor DNA has a base length of 10 or more.

[13] Use in the method according to

[10] or

[11] above of (a) a protein comprising the amino acid sequence shown in SEQ ID NO: 2 or 4, and / or (b) a protein comprising an amino acid sequence having 70% or more identity to the amino acid sequence shown in SEQ ID NO: 2 or 4 and having single-stranded DNA ligation activity.

[14] For use in the method according to

[10] or

[11] above, (a) a protein comprising the amino acid sequence shown in SEQ ID NO: 2 or 4, and / or (b) a protein comprising an amino acid sequence having 70% or more identity to the amino acid sequence shown in SEQ ID NO: 2 or 4 and having single-stranded DNA ligation activity.

[0012]

[15] A method for preparing a double-stranded DNA library from single-stranded DNA fragments, comprising: (A) ligating a single-stranded adapter sequence, the 5' end of which is phosphorylated, to a target single-stranded DNA fragment; (B) generating double-stranded DNA by DNA replication starting from the adapter of the ligated sequence; (C) ligating a topoisomerase-complexed double-stranded adapter sequence to the end of the double-stranded DNA to which no adapter sequence has been added; and (D) obtaining a library containing a plurality of double-stranded DNAs by PCR using the ligated double-stranded DNA as a template, wherein the ligation in step (A) is performed by a ligation method using: (a) a protein comprising the amino acid sequence shown in SEQ ID NO: 2 or 4, and / or (b) a protein comprising an amino acid sequence having 70% or more identity to the amino acid sequence shown in SEQ ID NO: 2 or 4 and having single-stranded DNA ligation activity.

[0013]

[16] A method for preparing a double-stranded DNA library from single-stranded DNA fragments, comprising: (i) ligating a single-stranded adapter sequence A1 having a phosphorylated 5'-end to the 3'-end of a single-stranded DNA fragment having dephosphorylated ends to generate an adapted single-stranded DNA; (ii) annealing a single-stranded adapter sequence A2 to the adapter sequence A1 portion contained in the adapted single-stranded DNA, and then extending the 3'-end of the adapter sequence A2 with a DNA polymerase to generate an adapted double-stranded DNA; (iii) reacting a double-stranded adapter sequence B1, which has only one 5'-end phosphorylated and has a topoisomerase recognition sequence in a region including the 3'-end complementary to the 5'-end, with a topoisomerase to generate a topoisomerase-conjugated double-stranded adapter sequence B2 in which the topoisomerase is conjugated to the 3'-end of the recognition sequence; (iv) ligating a topoisomerase-complexed double-stranded adaptor sequence B2 to the end of the adaptor-tagged double-stranded DNA to which no adaptor sequence has been added, thereby generating a double-stranded DNA with adaptors attached at both ends; and (v) obtaining a library containing a plurality of double-stranded DNAs by PCR using the double-stranded DNA with adaptors attached at both ends as a template, wherein the ligation and generation in step (i) are carried out by a ligation method using: (a) a protein comprising the amino acid sequence shown in SEQ ID NO: 2 or 4, and / or (b) a protein comprising an amino acid sequence having 70% or more identity to the amino acid sequence shown in SEQ ID NO: 2 or 4 and having single-stranded DNA ligation activity.

[0014] In the preparation method described in

[16] above, the topoisomerase-complexed double-stranded adapter sequence B2 preferably does not ligate with the double-stranded adapter sequence C generated by annealing the unreacted single-stranded adapter sequence A1 with the unreacted single-stranded adapter sequence A2. Furthermore, it is preferable that the double-stranded adapter sequence B1 has a nick in a region including the phosphorylated 5'-end, and the single-stranded adapter sequence A1 has uracil or dSpacer in the sequence. Furthermore, it is preferable that step (iv) includes adding an endonuclease to the reaction system after the generation.

[0015]

[17] A double-stranded DNA library obtained by the preparation method according to

[15] or

[16] above.

[0016] According to the present invention, it is possible to provide a single-stranded DNA ligation composition as a novel enzyme composition having efficient single-stranded DNA ligation activity, a single-stranded DNA ligation agent, a single-stranded DNA ligation kit, etc. By using the single-stranded DNA ligation composition, etc. of the present invention, single-stranded DNAs serving as donors and acceptors can be ligated without adding ribotails, which is useful in that it enables, for example, highly efficient preparation of a sequence library.

[0017] Figure 1: Diagram of the identification of single-stranded DNA ligase. A. Phylogenetic tree of proteins homologous to TS2126 RNA ligase. The area within the dashed box is enlarged in the right panel. B. Assay design used. TdT during the reaction ligates several adenylates to the 3' end of the acceptor. This RNA enhances the ligation activity of the RNA ligase. This is known as TACS ligation, and several examples of highly efficient ligation reactions have been confirmed in the presence of TdT. Ligation occurring in the absence of TdT indicates that the enzyme possesses genuine single-stranded DNA ligation activity. C. Gel image of an actual screening run. The band shifts upward when ligation occurs. Figure 2: Phylogenetic relationships among candidate proteins. A. Partial phylogenetic tree. Homology of the amino acid sequences of proteins homologous to TS2126 RNA ligase. The same enlarged portion of Figure 1A is shown. B. Multiple alignment of the amino acid sequences shown in A. WP_172959156 and RTI02525 have the exact same amino acid sequence except for the N-terminal extension. The same applies to WP_081892735 and WP_038069792. [Figure 3] Dual affinity purification of six candidate proteins. A. Purification strategy. B-D. SDS-PAGE analysis of purified proteins. Lane numbers are as shown in A. The lysate before purification and the purified proteins were analyzed on anyKd MiniProtean TGX precast gel (Bio-rad Laboratories, Hercules, CA). After electrophoresis, the gel was stained with Bullet CBB Stain One (Nakai Tesque, Kyoto, Japan) and photographed using a ChemiDoc Touch imaging system (Bio-Rad). [Figure 4] Optimal reaction temperature for AYJ73970. A. Assay design. Numbers in italic font indicate the length of the oligonucleotide. B, C. Analytical images by denaturing gel electrophoresis after the reaction. 50 mM HEPES-KOH, pH 7.5, 10 mM MgCl 2A 25 μL reaction mixture containing 0.05% (v / v) Tritton X-100, 400 μM ATP, 16% (w / v) PEG 6000, 5 pmol of acceptor DNA (N50, see Table 1), 50 pmol of donor DNA (P-anti-PEA2-thio5-P, see Table 1), and 3 μg of SDL (AYJ73970) was prepared and incubated at each temperature for 1 hour. A control lane was prepared without ligase. After the reaction, 20 μL of Buffer B2 (Qiagen, Hilden, Germany) and 5 μL of Proteinase K (Qiagen) were added and incubated at 50°C for 15 minutes. Next, 2 μL of Sera-Mag carboxylate beads (Cytiva, Marlborough, MA) and 50 μL of ethanol were added to the reaction mixture and incubated at room temperature for 5 minutes. After rinsing the beads with 200 μL of 70% ethanol, the purified DNA was eluted with 10 mM Tris-Acetate, pH 8.0. The purified DNA was mixed with an equal volume of formamide and heated at 70°C for 5 minutes before being loaded onto a 10% Novex TBE-urea gel (Thermofisher Scientific, Waltham, MA). After electrophoresis, the gel was stained with SYBR Gold gel stain (Thermofisher Scientific) and images were captured using a ChemiDoc Touch imaging system. In Figure 4 and subsequent figures (Figures 4 to 14) of the present application, the term "SDL" refers to the ligase derived from Thermus phage phiLo (Tph ssDNA ligase, GenBank accession number: AYJ73970), and may be referred to simply as "AYJ73970." [Figure 5] A diagram showing the effects of polyethylene glycol (PEG) of various molecular weights. A. Assay design. B-D. Denaturing gel electrophoresis images of reaction products. 50 mM Tris-HCl, pH 8.5, 5 mM MgCl 2Reactions were prepared in 25 μL containing 0.05% (v / v) Tritton X-100, 400 μM ATP, 5 pmol acceptor DNA (N50), 50 pmol donor DNA (P-anti-PEA2-thio5-P, see Table 1), 3 μg SDL, and the indicated concentrations of each PEG, and incubated at 37°C for 1 hour. Reactions without ligase were prepared as controls. The analysis method for the reaction results was the same as in Figure 4. Figure 6: Optimization of reaction pH and buffer system. A. Assay design. B. Denaturing gel electrophoresis image of reaction products. 50 mM of the indicated buffer components, 5 mM MgCl. 2 A 25 μL reaction mixture containing 0.05% (v / v) Tritton X-100, 400 μM ATP, 16% (w / v) PEG 6000, 5 pmol acceptor DNA (N50), 50 pmol donor DNA (P-anti-PEA2-thio5-P, see Table 1), and 3 μg SDL was prepared and incubated at 37°C for 1 hour. A control reaction mixture lacking ligase was prepared. The analytical method for the reaction results was the same as in Figure 4. Figure 7 shows the optimal ion concentration for ssDNA ligase. A. Assay design. B, C. Denaturing gel electrophoresis images of the reaction products. In addition to the indicated ions, 50 mM Tris-HCl, pH 8.5, 5 mM MgCl 2 A 25 μL reaction solution containing 0.05% (v / v) Tritton X-100, 400 μM ATP, 16% (w / v) PEG6000, 5 pmol of acceptor DNA (N50), 50 pmol of donor DNA (P-anti-PEA2-thio5-P, see Table 1), and 3 μg of SDL was prepared and incubated at 37°C for 1 hour. The analysis method for the reaction results was the same as in Figure 4. [Figure 8] Optimal magnesium chloride (MgCl) for ssDNA ligase. 2) concentrations. A. Assay design. B, C. Denaturing gel electrophoresis images of reaction products. 25 μL of reaction mixture was prepared containing the indicated magnesium concentrations, 50 mM Tris-HCl, pH 8.5, 0.05% (v / v) Tritton X-100, 400 μM ATP, 16% (w / v) PEG 6000, 5 pmol acceptor DNA (N50), 50 pmol donor DNA (P-anti-PEA2-thio5-P, see Table 1), and 3 μg SDL, and incubated at 37°C for 1 hour. The analysis method for the reaction results was the same as in Figure 4. [Figure 9] Investigation of the minimum size of donor and acceptor for ssDNA ligase. A, C. Assay design for investigating the nucleotide length required for donor (A) and acceptor (C). B, D. Denaturing gel electrophoresis image of reaction products. 50 mM Tris-HCl, pH 8.5, 10 mM MgCl 2 A 25 μL reaction mixture containing 0.05% (v / v) Tritton X-100, 400 μM ATP, 32% (v / v) PEG 600, oligonucleotides (described below), and 3 μg of SDL was prepared and incubated at 37°C for 1 hour. The reaction mixture was diluted 1:9 with formamide, heat-denatured at 95°C for 3 minutes, and loaded onto a 10% Novex TBE-urea gel. After electrophoresis, the FAM fluorescent signal was captured without staining using a ChemiDoc Touch imaging system. Assays to examine donor length used 50 pmol of acceptor DNA (FAM-N40, see Table 1) and 100 pmol of donor DNA (chemically synthesized with a mixed sequence of four bases). To examine the acceptor length, 50 pmol of donor DNA (P-anti-PEA2-thio5-FAM, see Table 1) and 100 pmol of acceptor DNA (chemically synthesized with a mixed sequence of four bases, phosphorylated at both the 5' and 3' ends) were used. [Figure 10] Reactivity of ssDNA ligase toward RNA. A. Assay design. B, C. Denaturing gel electrophoresis images of the reaction products. 50 mM Tris-HCl, pH 8.5, 10 mM MgCl 2A 25 μL reaction mixture containing 0.05% (v / v) Triton X-100, 400 μM ATP, 32% (v / v) PEG600, donor (DNA or RNA, FAM-N40 or FAM-rN40, see Table 1), acceptor (DNA or RNA, N20 or rN20, see Table 1), and 3 μg of SDL was prepared and incubated at 37°C for 1 hour. The reaction mixture (1 μL) was mixed with 10 μL of formamide, incubated at 70°C for 5 minutes, and loaded onto a 10% Novex TBE-Urea gel. After electrophoresis, the FAM fluorescent signal was imaged using a ChemiDoc Touch imaging system without staining (B). The gel was then stained with SYBR Gold and imaged again (C). [Figure 11] Ligation activity of SDL for ssDNA and dsDNA. A. Assay design. dsDNA was prepared by PCR. After PCR, half of the dsDNA was used as is, and the other half was blunted by adding Klenow fragment. The remaining single-stranded acceptor DNA was prepared by chemical synthesis. B. Denaturing gel electrophoresis image of the reaction product. 50 mM Tris-HCl, pH 8.5, 10 mM MgCl 2A 25 μL reaction mixture containing 0.05% (v / v) Triton X-100, 400 μM ATP, 32% (v / v) PEG600, 50 pmol of donor (P-anti-PEA2-thio5-P, see Table 1), 80 ng of acceptor DNA (single-stranded or double-stranded, N50, N100, M13FR; dsDNA is described below), and 3 μg of SDL was prepared and incubated at 37°C for 1 hour. One μL of the reaction mixture was mixed with 10 μL of formamide and incubated at 70°C for 5 minutes, after which each aliquot was loaded onto a 10% Novex TBE-Urea gel. After electrophoresis, the gel was stained with SYBR Gold stain and photographed. Double-stranded model DNA was prepared as follows. A 50-μL reaction mixture containing 5 μL of ExTaq Buffer, 4 μL of 2.5 mM dNTPs, 20 pmol of M13F and M13RV (see Table 1), 10 pg of pUC19 vector, and 5 U of ExTaq was prepared. The mixture was incubated at 95°C for 1 minute, followed by 30 cycles of incubation at 95°C for 15 seconds, 55°C for 30 seconds, and 72°C for 30 seconds, followed by a final incubation at 72°C for 1 minute. 1 μL of Exonuclease I was added, followed by incubation at 37°C for 15 minutes. If necessary, 1 μL of Klenow fragment (NEB) was added, followed by an additional 15-minute incubation. The DNA was then purified using a QiaQuick PCR purification kit (Qiagen). [Figure 12] Preparation of a sequencing library from ssDNA (SDL-TOPO scheme). A, B. Library preparation schemes for TACS-TOPO (A) and SDL-TOPO (B). Because TACS-TOPO libraries contain RNA, bisulfite treatment cannot be applied. C-H. Analysis of sequence reads from libraries prepared using the SDL-TOPO method. Sequencing results for libraries without (D, E) and with (G, H) bisulfite treatment for N50 (C-E) and blood-derived cell-free DNA (G, H) are shown. Significant changes in base composition can be seen as a result of bisulfite treatment.The sequence of the complementary strand of bisulfite-treated DNA was analyzed. In other words, the bisulfite treatment dramatically reduced the content of the base G, while increasing the content of the base A. Details of library preparation (SDL-TOPO method) are as follows: <SDL-TOPO method> A 25-μL solution containing target single-stranded DNA, 2.5 μL of 10×SDL buffer, 1 μL of 100 mM ATP, 25 pmol of adapter (P-AR-thio5-NH2 for native DNA, 25 μM P-AR-Bs-thio5-NH2 for bisulfite treatment; see Table 1), 7.5 μL of PEG600, and 3 μg of SDL was prepared and incubated at 37°C for 1 hour. After heating at 95°C for 5 minutes to inactivate the enzyme, 5 μL of 10x ExTaq buffer, 4 μL of 2.5 mM dNTP, 50 pmol primer oligo (NH2-AF for native, NH2-AF-Bs for bisulfite treatment; see Table 1), and 1 μL of Hot-Start Gene Taq (Nippon Gene, Toyama, Japan) were added to the reaction solution to prepare a 50 μL reaction solution. This was successively incubated at 95°C for 3 minutes, 45°C for 5 minutes, and 65°C for 15 minutes. Next, 45 μL of Buffer B2 (Qiagen) and 5 μL of Proteinase K (Qiagen) were added to the reaction solution, and the mixture was incubated at 50°C for 15 minutes. 100 μL of AxyPrep PCR clean was added to the reaction mixture and incubated at room temperature for 5 minutes. The beads were then washed twice with 200 μL of 50-bp cutoff solution. After rinsing the beads with 70% (v / v) ethanol, the DNA was eluted with 45 μL of 10 mM Tris-Acetate. 5 μL of 10x ExTaq buffer and 1 μL of 150 ng / μL VOC were added to 45 μL of the purified DNA solution and incubated at 25°C for 15 minutes. Bisulfite-specific VOC was used for samples that were subsequently bisulfite-treated, while native VOC was used for samples that were not. After the adapter ligation reaction, 45 μL of Buffer B2 (Qiagen) and 5 μL of Proteinase K (Qiagen) were added to the reaction mixture and incubated at 50°C for 15 minutes.Next, 50 μL of AxyPrep PCR clean was added to the reaction mixture and incubated at room temperature for 5 minutes. The beads were washed twice with 200 μL of 50-bp cutoff solution and once with 200 μL of 70% (v / v) ethanol, after which the library was eluted with 20 μL of 10 mM Tris-Acetate. If necessary, the eluted library was bisulfite-treated. After adding 25 μL of 2xKOD One (Toyobo) and 10 pmol each of Primer-3 and Index-1 (Table 1) to the resulting library, the reaction was incubated at 95°C for 1 minute, followed by the appropriate number of incubation cycles: 95°C for 15 seconds, 55°C for 15 seconds, and 72°C for 30 seconds, followed by a final incubation at 72°C for 3 minutes. The amplified library was loaded onto 2% E-Gel Ex to confirm the amplification status. [Figure 13] Library preparation for whole-genome bisulfite sequencing using SDL. A-C. Schematic diagram of library preparation using the postbisulfite adapter tagging (PBAT) strategy. The original PBAT method (PBAT or rPBAT method, see Miura F. et al., 2012 (cited above)) involves two rounds of random priming (RP) to introduce adapter sequences (A). However, the more RPs are repeated, the shorter the insert becomes. Therefore, in the second version of PBAT, the latter of the two RPs was replaced with TACS ligation (tPBAT, see Miura F. et al., 2019 (cited above)) (B). Replacing TACS ligation in tPBAT with SDL enabled the realization of a new protocol, sPBAT (C). D. Comparison of library yields between sPBAT and tPBAT. IMR-90 cells and genomic DNA derived from human female peripheral blood were used as models. Three experiments were performed, and the average yield is shown. Error bars indicate the variation (standard deviation) of the results. Details of the sPBAT protocol are as follows.<sPBAT Protocol> 5 μL of 10x NEBuffer 2, 4 μL of 2.5 mM dNTPs, and 1 μL of 100 μM PEA2-N4 were added to bisulfite-treated DNA (BS-DNA) and incubated at 95°C for 3 minutes and 4°C for 5 minutes. Random priming was initiated by adding 1 μL of 5 mg / ml Klenow fragment exo(-). The reaction solution was incubated at 4°C for 15 minutes, then heated to 37°C at a rate of +1°C / min and further incubated at 37°C for 30 minutes. The reaction was terminated by incubating at 70°C for 10 minutes. 50 μL of AxyPrep PCR clean was then added and incubated at room temperature for 5 minutes. After washing the beads twice with 200 μL of 300 bp cutoff solution and once with 200 μL of 70% ethanol, the purified DNA was eluted with 10 μL of 10 mM Tris-Acetate, pH 8.0. To 10 μL of purified DNA, 2.5 μL of 10x SDL, 1 μL of 100 mM ATP, 25 pmol of adapter (P-PEA1-thio5-NH2), and 7.5 μL of PEG600 were added and incubated at 95°C for 5 minutes. The reaction was then equilibrated at 37°C for 5 minutes. Five μg of SDL was then added to the reaction, which was then incubated at 37°C for 1 hour. The reaction was stopped by heating at 95°C for 5 minutes, after which 25 μL of water and 50 μL of AxyPrep PCR clean were added to the reaction, and the reaction was incubated at room temperature for 5 minutes. After washing the beads with 70% ethanol, the library was eluted with 25 μL of 10 mM Tris-Acetate, pH 8.0. To this purified DNA, 25 μL of 2xKOD One (Toyobo) and 10 pmol each of Primer-3 and Index-1 (Table 1) were added to prepare a 50 μL reaction solution. The reaction solution was then incubated at 95°C for 1 minute, followed by two cycles of incubation at 95°C for 15 seconds, 55°C for 15 seconds, and 72°C for 30 seconds, followed by a final incubation at 72°C for 1 minute.50 μL of AxyPrep PCR clean was added to the reaction mixture and incubated at room temperature for 5 minutes. The beads were washed twice with 200 μL of 400 bp cutoff solution and once with 200 μL of 70% ethanol. The purified library was finally eluted with 20 μL of 10 mM Tris-Acetate, pH 8.0. The library molar concentration was determined using Takara Bio Inc.'s Library Quantitation Kit. E. Basic statistics of the methylome data for the IMR-90 library. Sequencing was performed only on libraries prepared from IMR-90. F. Genome-wide comparison plot of DNA methylation levels calculated for the IMR-90 library. The average methylation levels of 1000-bp-bin CpG sites were compared between sPBAT and tPBAT. Only CpG sites covered by at least five reads were used in this calculation. G, H. Comparison of GC content-dependent coverage bias in IMR-90 libraries was performed. The graph shows the tPBAT(G) and sPBAT(H) libraries. The horizontal axis of this graph represents the GC percentage of 1000-bp bins, and the vertical axis represents the coverage frequency (orange box plot, scale on the left) and genomic distribution of the bins (green bars, scale on the right). [Figure 14] This shows that SDL is effective for cDNA analysis. A. Procedure for preparing a cDNA library from total RNA with amplification adapter sequences ligated to both ends. B. Browser shot showing the distribution of reads mapped to the reference genome. Integrative Genomics Viewer (IGV) was used. Details of the library preparation protocol are as follows. <Library Preparation Protocol: Long-Read Sequencing of Saccharomyces cerevisiae cDNA> (i) Total RNA Extraction Total RNA was extracted from the vegetative budding yeast strain S288C cultured in YPD medium using a previously reported method (see Miura F. et al., 2008 (see Non-Patent Document 15)).(ii) cDNA synthesis: Reverse transcription using SuperScript IV (Thermofisher Sciences) was performed in combination with enzymatic removal of excess primers using exonuclease I. 3 μg of total RNA was mixed with 50 pmol of PEA1-dT20V (Table 1), diluted to 10 μL with water, and heated at 70°C for 5 minutes. After cooling on ice for 5 minutes, 4 μL of 5x SSIV buffer, 4 μL of 2.5 mM dNTPs, 1 μL of 100 mM DTT, and 1 μL of exonuclease I (NEB) were added and the mixture was incubated at 37°C for 15 minutes. To this reaction mixture, 1 μL of 200 U / μL SuperScript IV was added and the mixture was incubated at 42°C for 15 minutes, 50°C for 45 minutes, and 80°C for 10 minutes. 1 μL of 50 U / μL RNase If (NEB) was added to the reaction mixture and the mixture was incubated at 37°C for 30 minutes and 80°C for 10 minutes. 30 μL of water and 50 μL of AxyPrep PCR clean were added and the mixture was incubated at room temperature for 5 minutes. After that, the beads were washed twice with 200 μL of 300-bp cutoff solution and once with 200 μL of 70% (v / v) ethanol, and the purified cDNA was eluted with 10 μL of 10 mM Tris-Acetate, pH 8.0. (iii) Second Adapter Ligation with SDL: A 25-μL reaction mixture containing 2.5 μL of 10× SDL buffer, 1 μL of 100 mM ATP, 25 pmol of P-anti-PEA2-thio5-P, 10 μL of PEG600, and 3 μg of SDL was prepared for 10 μL of purified cDNA solution. The reaction mixture was then incubated at 37°C for 1 hour and 80°C for 10 minutes. Next, 5 μL of 10× ExTaq buffer, 4 μL of 2.5 mM dNTPs, 50 pmol of PEA2, and 1 μL of 5 U / μL ExTaq HS were added to the reaction mixture, and the mixture was incubated at 95°C for 3 minutes, 55°C for 5 minutes, and 72°C for 30 minutes. After adding 45 μL of buffer B2 and 5 μL of proteinase K and incubating at 50°C for 15 minutes, 50 μL of AxyPrep PCR clean was added and incubated at room temperature for 5 minutes. The beads were then washed twice with 200 μL of 300-bp cutoff solution and once with 200 μL of 70% (v / v) ethanol.The library was finally eluted with 25 μL of 10 mM Tris-Acetate, pH 8.0. (iv) cDNA PCR Amplification: 25 μL of 2xKOD One and 10 pmol each of Primer-3 and Index-1 were added to the 25 μL eluted adapter-ligated cDNA. After incubation at 95°C for 1 minute, 12 cycles of incubation were performed: 95°C for 15 seconds, 55°C for 30 seconds, and 72°C for 3 minutes. After a final incubation at 72°C for 3 minutes, the reaction mixture was mixed with 50 μL of AxyPrep PCR clean and incubated at room temperature for 5 minutes. After washing the beads twice with 200 μL of 300-bp cutoff solution and once with 200 μL of 70% (v / v) ethanol, the amplified cDNA was eluted with 20 μL of 10 mM Tris-Acetate, pH 8.0. The cDNA concentration after amplification was determined using the Qubit dsDNA BR Kit. (v) Nanopore Sequencing. Sequencing was performed using 800 ng of amplified cDNA. The sequencing was performed using a Flongle Flow Cell (FLO-FLG001, Oxford Nanopore Technologies) in combination with a Ligation Sequencing Kit (SQK-LSK110, Oxford Nanopore Technologies) according to the protocol provided with the Ligation Sequencing Amplifiers. The reads output in fastq format were mapped to the budding yeast reference genome sacCer3 using CLC Genomic Workbench (Qiagen), and the alignment was then exported in BED format and visualized using IGV.

[0018] The present invention will be described in detail below. The scope of the present invention is not limited to these descriptions, and other than the following examples, modifications can be made as appropriate without departing from the spirit of the present invention. This specification encompasses the entire specification of Japanese Patent Application No. 2023-088967 (filed May 30, 2023), which is the basis for claiming priority to this application. All publications cited in this specification, such as prior art documents, published patent applications, patent publications, and other patent documents, are incorporated herein by reference.

[0019] 1. Overview of the Present Invention The existence of an enzyme with potent single-stranded DNA ligation activity would be beneficial for the development of various applications in molecular biology. However, previously known enzymes have only limited activity. The present inventors searched databases for amino acid sequences homologous to "TS2126 RNA ligase" (see Non-Patent Document 9, cited above), which has the highest single-stranded DNA ligation activity among known enzymes, and identified from these sequences those with superior single-stranded DNA ligation activity. In particular, a ligase derived from Thermus phage phiLo (Tph ssDNA ligase, GenBank accession number: AYJ73970) exhibited significantly higher single-stranded DNA ligation activity than TS2126 RNA ligase. Enzyme proteins with single-stranded DNA ligation activity discovered by the present inventors, such as this Tph ssDNA ligase, will be useful for the development of various applications, including library preparation for sequencing. In the present invention and the entire application, including the present specification, the above enzyme (Tph ssDNA ligase, GenBank accession number: AYJ73970) is referred to as "SDL."

[0020] 2. Composition for ligating single-stranded DNA, etc. The composition for ligating single-stranded DNA according to the present invention is a composition used for ligating one or more types of single-stranded DNA as acceptors with one or more types of single-stranded DNA as donors, and contains the following proteins (a) and / or (b) (proteins that function as enzymes having single-stranded DNA ligation activity; hereinafter, also referred to as "proteins according to the present invention"):

[0021] (a) A protein comprising the amino acid sequence shown in SEQ ID NO: 2 or 4. (b) A protein comprising an amino acid sequence having 70% or more identity to the amino acid sequence shown in SEQ ID NO: 2 or 4, and having single-stranded DNA ligation activity.

[0022] The amino acid sequence shown in SEQ ID NO: 2 is registered in GenBank (https: / / www.ncbi.nlm.nih.gov / genbank / ) under accession number AYJ37970. Examples of nucleotide sequences encoding the amino acid sequence shown in SEQ ID NO: 2 include various nucleotide sequences synthesized based on the amino acid sequence, and a preferred example is the nucleotide sequence shown in SEQ ID NO: 1.

[0023] The amino acid sequence shown in SEQ ID NO: 4 is registered in GenBank under the accession number WP_119360902. Examples of nucleotide sequences encoding the amino acid sequence shown in SEQ ID NO: 4 include various nucleotide sequences synthesized based on the amino acid sequence, and a preferred example is the nucleotide sequence shown in SEQ ID NO: 3. The protein having the amino acid sequence shown in SEQ ID NO: 2 or 4 was first identified by the present inventors as a protein that functions as an enzyme with single-stranded DNA ligation activity.

[0024] The protein of the present invention is not limited to a protein consisting of the amino acid sequence shown in SEQ ID NO: 2 or 4, but also includes proteins containing the amino acid sequence shown in SEQ ID NO: 2 or 4. Preferred examples of the protein of the present invention include proteins (so-called mutant proteins) that contain an amino acid sequence in which one or several amino acids are deleted, substituted, or added in the amino acid sequence shown in SEQ ID NO: 2 or 4 and have single-stranded DNA ligation activity.

[0025] Here, the "amino acid sequence in which one or several amino acids are deleted, substituted, or added" is preferably an amino acid sequence in which, for example, about 1 to 10, preferably 1 to several, 1 to 5, 1 to 4, 1 to 3, 1 to 2, or 1 amino acid is deleted, substituted, or added. The introduction of such mutations as deletion, substitution, or addition can be carried out using a mutation introduction kit utilizing site-directed mutagenesis, for example, GeneTailor TMThis can be performed using a Site-Directed Mutagenesis System (Invitrogen), a TaKaRa Site-Directed Mutagenesis System (Prime STAR (registered trademark) Mutagenesis Basal kit, Mutan (registered trademark)-Super Express Km, etc.: manufactured by Takara Bio Inc.), etc. Furthermore, whether or not the above-mentioned deletion, substitution, or addition mutation has been introduced can be confirmed using various amino acid sequencing methods, and structural analysis methods such as X-ray and NMR.

[0026] Preferred examples of the protein according to the present invention include proteins (so-called mutant proteins) that contain an amino acid sequence having 70% or more identity (homology) to the amino acid sequence shown in SEQ ID NO: 2 or 4 and have single-stranded DNA joining activity. More preferably, the identity is 75% or more, 80% or more, 81% or more, 82% or more, 83% or more, 84% or more, 85% or more, 86% or more, 87% or more, 88% or more, 89% or more, 90% or more, 91% or more, 92% or more, 93% or more, 94% or more, 95% or more, 96% or more, 97% or more, 98% or more, or 99% or more.

[0027] In the present invention, "having single-stranded DNA ligation activity" means having at least the activity of directly ligating donor DNA and acceptor DNA, both of which are single-stranded DNA (ligation activity). The activity of directly ligating DNAs as used herein excludes, for example, the activity of ligating single-stranded DNAs in which ribotails (several RNA-constituting bases such as adenylic acid) have been added to either end of the donor DNA or acceptor DNA (the end that binds to the other). However, the protein of the present invention may also have such an activity, and is not limited thereto. Whether a protein of the present invention has "single-stranded DNA ligation activity" can be confirmed, for example, by the sPBAT method described in the Examples below.

[0028] The protein according to the present invention may be a peptide derived from a natural product, or may be one obtained by artificial chemical synthesis, and is not limited thereto. A protein derived from a natural product may be obtained directly from a natural product by known recovery and purification methods, or may be produced by genetic engineering using a gene encoding the amino acid sequence of the protein (including the mutant protein described above) by known genetic recombination techniques. For example, the encoding gene may be incorporated into various expression vectors or the like, introduced into cells, and expressed, and then obtained by known recovery and purification methods. Alternatively, a commercially available kit, for example, the PROTEIOS reagent kit, may be used. TM (Toyobo), TNT TM System (Promega), synthesis equipment PG-Mate TM The protein of the present invention may be produced by a cell-free protein synthesis system using, for example, Toyobo (Toyobo) and RTS (Roche Diagnostics), and then obtained by known recovery and purification methods, without any particular limitation.

[0029] Chemically synthesized proteins can be obtained using known protein synthesis methods. Examples of synthesis methods include the azide method, acid chloride method, acid anhydride method, mixed acid anhydride method, DCC method, active ester method, carboimidazole method, and oxidation-reduction method. Both solid-phase synthesis and liquid-phase synthesis can be used for the synthesis. A commercially available protein synthesizer may also be used. After the synthesis reaction, the protein can be purified by a combination of known purification methods such as chromatography.

[0030] The present invention can include a derivative of the protein in addition to or instead of the protein of the present invention. The derivative includes all products that can be prepared from the protein, such as products in which some of the constituent amino acids have been substituted with unnatural amino acids, or products in which some of the constituent amino acids (mainly their side chains) have been chemically modified.

[0031] Furthermore, the present invention can include salts of the protein and / or derivative of the present invention together with or instead of the protein and / or derivative of the protein. Such salts are preferably physiologically acceptable acid addition salts or basic salts. Examples of acid addition salts include salts with inorganic acids such as hydrochloric acid, phosphoric acid, hydrobromic acid, and sulfuric acid, and salts with organic acids such as acetic acid, formic acid, propionic acid, fumaric acid, maleic acid, succinic acid, tartaric acid, citric acid, malic acid, oxalic acid, benzoic acid, methanesulfonic acid, and benzenesulfonic acid. Examples of basic salts include salts with inorganic bases such as sodium hydroxide, potassium hydroxide, ammonium hydroxide, and magnesium hydroxide, and salts with organic bases such as caffeine, piperidine, trimethylamine, and pyridine.

[0032] Such salts can be prepared using a suitable acid, such as hydrochloric acid, or a suitable base, such as sodium hydroxide, for example, by treatment in water or in a liquid containing an inert, water-miscible organic solvent, such as methanol, ethanol, or dioxane, using standard protocols.

[0033] Regarding the single-stranded DNA as the acceptor and the single-stranded DNA as the donor to be ligated by the single-stranded DNA ligation composition of the present invention, for example, the base length of the acceptor DNA is preferably 12 or more bases (or may be 14 or more bases, 16 or more bases, 18 or more bases, 20 or more bases, 22 or more bases, 24 or more bases, 26 or more bases, 28 or more bases, 30 or more bases, 32 or more bases, 34 or more bases, 36 or more bases, 38 or more bases, or 40 or more bases), and the base length of the donor DNA is preferably 10 or more bases (or may be 11 or more bases, 12 or more bases, 13 or more bases, 14 or more bases, 15 or more bases, 16 or more bases, 17 or more bases, 18 or more bases, 19 or more bases, or 20 or more bases). When the base lengths of the acceptor DNA and donor DNA are within the above ranges, stable single-stranded DNA ligation activity can be achieved.

[0034] The single-stranded DNA ligation composition of the present invention preferably further contains, but is not limited to, PEG. The type of PEG is not limited, and for example, one or more types selected from PEG400, PEG600, PEG1540, PEG2000, PEG4000, and PEG6000 can be used. PEG400 and PEG600 are preferably used in an amount of, for example, 30 to 60% by weight (or alternatively, 30 to 50% by weight, or alternatively, 30 to 40% by weight) relative to the composition. PEG1540 and PEG2000 are preferably used in an amount of, for example, 20% by weight or more (or alternatively, 25% by weight or more, or alternatively, 30% by weight or more) relative to the composition. PEG4000 and PEG6000 are preferably used in an amount of, for example, 15% by weight or more (or alternatively, 20% by weight or more, or alternatively, 25% by weight or more) relative to the composition.

[0035] The reaction temperature when a single-stranded DNA as an acceptor and a single-stranded DNA as a donor are ligated using the composition for ligating single-stranded DNA of the present invention is not limited, but is preferably, for example, 20 to 49°C (or alternatively, 30 to 45°C, 35 to 45°C, or 37 to 42°C), and more preferably 37°C.

[0036] The pH of the reaction solution during the ligation reaction is not limited, but is preferably, for example, pH 7.5 to 9.5 (or may be pH 8.0 to 9.5, or pH 7.5 to 9.0). Furthermore, other components that may be contained in the reaction solution include, but are not limited to, magnesium chloride (MgCl 2 ), ammonium sulfate, sodium chloride, potassium chloride, ATP, etc. 2is desirably essential in the reaction solution, preferably at a concentration of, for example, 1.0 to 20.0 mM (or alternatively, 2.5 to 20 mM, or alternatively, 5 to 20 mM). Ammonium sulfate is preferably, for example, less than 20 mM (or alternatively, less than 16 mM, or alternatively, less than 12 mM), and the total of sodium chloride and potassium chloride is preferably 50 mM or less. Note that these other components may be contained in the reaction solution during the ligation reaction, or may be included in advance as a constituent component of the composition for ligating single-stranded DNAs according to the present invention, and are not limited thereto.

[0037] The present invention also provides a method for producing ligated single-stranded DNA or a method for ligating single-stranded DNAs, which comprises contacting the protein of the present invention (and thus the composition for ligating single-stranded DNA of the present invention) with one or more single-stranded DNAs as acceptors and one or more single-stranded DNAs as donors, thereby ligating the acceptor DNAs and the donor DNAs. The detailed explanation for the composition for ligating single-stranded DNAs of the present invention described above can be applied, as appropriate, to the various conditions for carrying out these methods.

[0038] Similar to the invention relating to the composition for ligating single-stranded DNAs described above, the present invention also includes an invention relating to a single-stranded DNA ligation agent and a kit for ligating single-stranded DNAs, which are used to ligate one or more single-stranded DNAs as acceptors and one or more single-stranded DNAs as donors. For details of the components contained in the ligation agent and kit, the various explanations for the composition for ligating single-stranded DNAs described above can be applied as appropriate.

[0039] The present invention also encompasses inventions relating to the protein of the present invention for use in the above-mentioned method for producing ligated single-stranded DNA or method for ligating single-stranded DNAs, and use of the protein of the present invention in said methods.

[0040] Furthermore, the present invention also includes an invention relating to a method for preparing a double-stranded DNA library from single-stranded DNA fragments using the protein of the present invention, and an invention relating to a double-stranded DNA library obtained by said preparation method.

[0041] An example of the method for preparing a double-stranded DNA library (Preparation Method I) is a method for preparing a double-stranded DNA library from single-stranded DNA fragments, comprising the steps of: (A) ligating a single-stranded adapter sequence, the 5' end of which is phosphorylated, to target single-stranded DNA fragments; (B) generating double-stranded DNA by DNA replication starting from the adapter of the ligated sequence; (C) ligating a topoisomerase-complexed double-stranded adapter sequence to the end of the double-stranded DNA to which no adapter sequence has been added; and (D) obtaining a library containing a plurality of double-stranded DNAs by PCR using the ligated double-stranded DNA as a template, wherein the ligation in step (A) is carried out by a ligation method using: (a) a protein comprising the amino acid sequence shown in SEQ ID NO: 2 or 4, and / or (b) a protein comprising an amino acid sequence having 70% or more identity to the amino acid sequence shown in SEQ ID NO: 2 or 4 and having single-stranded DNA ligation activity.

[0042] Furthermore, a more detailed embodiment of the method for preparing a double-stranded DNA library (Preparation Method II) is, for example, a method for preparing a double-stranded DNA library from single-stranded DNA fragments, comprising the steps of: (i) ligating a single-stranded adapter sequence A1 having a phosphorylated 5'-end to the 3'-end of a single-stranded DNA fragment having dephosphorylated ends to generate an adapted single-stranded DNA; (ii) annealing a single-stranded adapter sequence A2 to the adapter sequence A1 portion contained in the adapted single-stranded DNA, and then extending the 3'-end of the adapter sequence A2 with a DNA polymerase to generate an adapted double-stranded DNA; (iii) reacting a topoisomerase with a double-stranded adapter sequence B1 having only one 5'-end phosphorylated and having a topoisomerase recognition sequence in a region including the 3'-end complementary to the 5'-end to generate a topoisomerase-conjugated double-stranded adapter sequence B2 in which the topoisomerase is conjugated to the 3'-end of the recognition sequence; (iv) ligating a topoisomerase-complexed double-stranded adaptor sequence B2 to the end of the adaptor-tagged double-stranded DNA to which no adaptor sequence has been added, thereby generating a double-stranded DNA with adaptors attached at both ends; and (v) obtaining a library containing a plurality of double-stranded DNAs by PCR using the double-stranded DNA with adaptors attached at both ends as a template, wherein the ligation and generation in step (i) are carried out by a ligation method using: (a) a protein comprising the amino acid sequence shown in SEQ ID NO: 2 or 4, and / or (b) a protein comprising an amino acid sequence having 70% or more identity to the amino acid sequence shown in SEQ ID NO: 2 or 4 and having single-stranded DNA ligation activity.

[0043] Here, in each aspect of the method for preparing a double-stranded DNA library (Preparation Methods I and II), the details of the proteins (a) and / or (b) and the ligation method using the proteins can be appropriately applied to the above-mentioned explanations regarding the protein of the present invention, as well as the above-mentioned explanations regarding the method for producing ligated single-stranded DNAs and the explanations regarding the method for ligating single-stranded DNAs. Furthermore, each of the above-mentioned aspects (Preparation Methods I and II) is not limited to including only the steps described above, and may also include any other steps.

[0044] Of the above-described aspects of the double-stranded DNA library preparation method (Preparation Methods I and II), the aspect related to Preparation Method II will be described in more detail below. Details of the aspect related to Preparation Method I can be understood by appropriately referring to the details of the aspect related to Preparation Method II.

[0045] Regarding step (i): The "single-stranded DNA fragments" that serve as insert DNA in library preparation are those whose both ends (5' and 3' ends) have been dephosphorylated. Next, a "single-stranded adapter sequence A1," which is single-stranded DNA with a phosphorylated 5' end, is ligated to the 3' end of the single-stranded DNA fragment. As described above, this ligation is performed by the ligation method using the protein of the present invention. Through this ligation, an "adapter-tagged single-stranded DNA" is generated. The details of how the adapter-tagged single-stranded DNA is generated in step (i) (including various reaction conditions, etc.) can be selected appropriately and are not particularly limited.

[0046] Regarding step (ii): This step converts the adaptor-tagged single-stranded DNA generated in step (i) into double-stranded DNA. Specifically, a single-stranded DNA "single-stranded adapter sequence A2" is annealed to the adapter sequence A1 portion of the generated adaptor-tagged single-stranded DNA. The single-stranded adapter sequence A2 (particularly its 3'-end portion) preferably has a base sequence complementary to at least a portion of the base sequence of the adapter sequence A1 portion. After this annealing, the 3'-end of the adapter sequence A2 is extended using a DNA polymerase. Examples of DNA polymerases include, but are not limited to, Taq DNA polymerase. In this way, "adaptor-tagged double-stranded DNA" is generated as double-stranded DNA. For details of the process of generating adaptor-tagged double-stranded DNA in step (ii) (including various reaction conditions, etc.), please refer to some steps of the "TACS-T4" library preparation method disclosed in the aforementioned Non-Patent Document 1 (BMC Biology, 2021).

[0047] Regarding step (iii), this is a step for preparing a "double-stranded adapter sequence B1," which is an adapter sequence for double-stranded DNA to be used in the so-called second ligation (specifically, the next step (iv)). First, in the double-stranded adapter sequence B1, the 5' end of one single-stranded DNA is phosphorylated, but the 5' end of the other single-stranded DNA is not phosphorylated. Furthermore, the double-stranded adapter sequence B1 has a topoisomerase recognition sequence in a region including the 3' end complementary to the phosphorylated 5' end. The topoisomerase is preferably topoisomerase I, and more preferably vaccinia virus topoisomerase I (VToI). Furthermore, examples of the VToI recognition sequence include, but are not limited to, 5'-CCTTT-3' or 5'-(C / T)CCTT-3'. VTopoI specifically recognizes this five-base sequence and forms a covalent bond with the phosphate group of the 3'-T. Simultaneously with this formation, the base sequence 3' to the 3'-T of the recognition sequence is cleaved. The region of the double-stranded adapter sequence B1 containing the phosphorylated 5'-end preferably contains a nick (a break in the base sequence). This nick is not limited to, but is preferably present at a base 5' to the sequence complementary to the VTopoI recognition sequence, and more preferably at a base one base 5' to the complementary sequence. Due to the presence of this nick, when the base sequence 3' to the 3'-T of the recognition sequence is cleaved, a sequence containing a sequence complementary to the cleavage sequence is also cleaved from the double-stranded adapter sequence B1. In this way, a "topoisomerase-complexed double-stranded adapter sequence B2" is generated. If the double-stranded adapter sequence B1 contains the nick, it is preferable that the nick or the deleted portion corresponding to the nick remain in the double-stranded adapter sequence B2.

[0048] Regarding step (iv): The topoisomerase-complexed double-stranded adapter sequence B2 produced in step (iii) is ligated to the end of the adapter-tagged double-stranded DNA produced in step (ii) that does not have the adapter sequence added. Topoisomerase (VTopoI) has the activity of ligating the phosphate group of the 3'-T to which it is covalently bound (i.e., the phosphorylated 3' end) with the dephosphorylated 5' end of the adapter-tagged double-stranded DNA (i.e., the hydroxyl group at the 5' end). This produces a "double-end-adapted double-stranded DNA." On the other hand, the topoisomerase-complexed double-stranded adapter sequence B2 does not, in principle, ligate to the unreacted double-stranded adapter (both strands have phosphorylated 5' ends) formed by annealing the single-stranded adapter sequence A1 and the single-stranded adapter sequence A2 (i.e., the free sequence A1 and sequence A2). Therefore, the formation of a dimer between the unreacted adapter and the adapter sequence B2 is effectively suppressed. Even if the dimer is accidentally formed, for example, if the double-stranded adapter sequence B1 has a nick as described in step (iii) (the nick or a deleted portion corresponding to the nick also remains in the double-stranded adapter sequence B2), and the single-stranded adapter sequence A1 has uracil in its sequence, the dimer can be degraded by adding a DNA endonuclease to the reaction system after the generation of the "double-stranded DNA with adapters added at both ends," thereby creating a state similar to that in which the dimer is not formed. Examples of the DNA endonuclease include those having the activity of hydrolyzing the N-glycosidic bond in uracil or inserting a nick into the DNA main chain on the 5' side of uracil, and preferred examples include UDG (uracil DNA glycosylase), APE1 (human-derived apurinic / apyrimidinic (AP) endonuclease), and EndoQ (endonuclease Q).The formed adapter dimer is degraded (split) by the removal of uracil by a DNA endonuclease, by a nick near the uracil, and by a nick in the double-stranded adapter sequence B2 (more specifically, by a nick at the junction with the double-stranded adapter sequence B2), resulting in its removal from the reaction system. Alternatively, a "dSpacer" spacer-modified oligo-DNA can be introduced in place of the uracil in the single-stranded adapter sequence A1. Here, the spacer-modified oligo-DNA is a base-free structure that can be introduced into the phosphodiester bond backbone of a DNA strand. It comes in types lacking only bases and types lacking both bases and deoxyribose rings, and the number of spacer arms can be selected. Because dSpacer lacks a base portion, it can reduce the stability of the double-stranded structure of the inserted sequence, and the stability of the double-stranded structure can also be controlled by the site and structure into which it is incorporated. Introducing dSpacer as described above not only reduces the formation of adapter dimers, but also allows for easy removal of adapter dimers by enzymatic degradation. Instead of or in combination with the dSpacer, an "ethynyl dSpacer" (in which an alkyne structure is bound to the 1'-position of the sugar to which a base is bound in a normal oligo-DNA chain) can also be used.

[0049] Step (v) is a step of performing PCR using the double-stranded DNA with adapters attached to both ends as a template to obtain a library containing a plurality of double-stranded DNAs. The PCR reaction conditions and purification conditions for the obtained PCR products (library) can be set as appropriate, but some steps of the "TACS-T4" library preparation method disclosed in the aforementioned Non-Patent Document 1 (BMC Biology, 2021) can be referred to as appropriate.

[0050] The present invention will be explained in more detail below by way of examples, but the present invention is not limited to these examples.

[0051] <Description of Materials and Methods> (1) Artificial Gene Synthesis, Protein Expression, and Purification The genes encoding the proteins registered in GenBank (https: / / www.ncbi.nlm.nih.gov / genbank / ) under accession numbers AYJ37970, WP_119360902, RTT02525, WP_081892735, WP_110532308, and WP_126206484 were synthesized using Twist. The following genes were synthesized by Biosciences (South San Francisco, CA) after being optimized for codon usage in E. coli K-12 (SEQ ID NO: 1 (AYJ37970), SEQ ID NO: 3 (WP_119360902), SEQ ID NO: 5 (RTT02525), SEQ ID NO: 6 (WP_081892735), SEQ ID NO: 7 (WP_110532308), SEQ ID NO: 8 (WP_126206484)). These genes were PCR amplified and subcloned into pET28a-StrepSL (SEQ ID NO: 9). The insert sequences were confirmed by Sanger sequencing and then used for expression induction.

[0052] Cultivation of E. coli transformants containing the expression vector, induction of protein expression, and purification of the recombinant protein followed the same method as used in a previous study on the purification of TS2126 RNA ligase (see Non-Patent Document 1, cited above). That is, a highly purified protein was obtained using a dual affinity strategy using two tags, a His6 tag and a Strep tag (see Non-Patent Document 1, cited above).

[0053] (2) Screening for enzymes with single-stranded DNA ligation activity A 25 μL reaction solution containing 2 pmol of acceptor DNA (N100, see Table 1 below), 25 pmol of donor DNA (P-anti-PEA2-thio5-P, see Table 1 below), 400 μM ATP, 50 mM HEPES-KOH, pH 7.5, 0.5% (v / v) Triton X-100, 20% (w / v) PEG 6000, and 2 μg of RNA ligase was prepared and incubated consecutively at 37°C, 45°C, 55°C, and 65°C for 30 minutes each, and then heated at 95°C for 5 minutes to inactivate the enzyme. Next, 25 μL of water, 45 μL of Buffer B2 (Qiagen, Hilden, Germany), and 5 μL of Proteinase K (Qiagen) were added, and the mixture was further incubated at 50°C for 15 minutes. 100 μL of isopropanol and 2 μL of Sera-Mag Carboxylate Magnetic Beads (Cytiva, Marlborough, MA) were added to the reaction mixture, mixed, and allowed to stand for 5 minutes. The magnetic beads were washed with 70% (v / v) ethanol, and the purified DNA was eluted with 10 μL of 10 mM Tris-Acetate, pH 8.0. The DNA was run on a 10% denaturing acrylamide gel, stained with SYBR Gold, and photographed.

[0054]

[0055] (3) Preparation of a sequencing library from single-stranded DNA The details of the sequencing library preparation are as follows. Human serum was obtained from Kohjin Bio Co., Ltd. (Saitama Prefecture, Japan). Cell-free DNA (cfDNA) was purified from 5 μL of serum using the PPAP method described above (see Non-Patent Document 1). Purified cfDNA, 50 mM Tris-HCl, pH 8.5, 10 mM MgCl 2A 25 μL reaction solution containing 0.05% (v / v) Triton X-100, 400 μM ATP, 25 pmol of adapter (P-anti-PEA2-thio5-P, see Table 1 above), 40% (v / v) PEG 600, and 3 μg of enzyme protein (screened for single-stranded DNA ligation activity) was prepared and incubated at 37°C for 1 hour. After heating at 95°C for 5 minutes to sterilize the enzyme, the reaction was supplemented with 5 μL of 10× ExTaq buffer, 4 μL of 2.5 mM dNTPs, 50 pmol of primer oligo (PEA2, see Table 1 above), and 1 μL of Hot-Start GeneTaq (Nippon Gene, Toyama, Japan). The reaction was sequentially incubated at 95°C for 3 minutes, 45°C for 5 minutes, and 65°C for 15 minutes. For the reaction, the mixture was supplemented with 5 μL of 500 mM EDTA-NaOH, pH 8.0, prepared as described above, and 1 μL of 1 mg / ml VTopoI-oligonucleotide complex (VOC), and incubated at 25° C. for 15 minutes.

[0056] The beads were then incubated with 50 μL of AxyPrep PCR Clean (Corning, NY) at room temperature for 5 minutes. The beads were washed twice with 200 μL of a solution containing 32% (v / v) PEG400, 1 M NaCl, and 50 mM Tris-HCl, pH 8.0. After rinsing the beads with 70% (v / v) ethanol, the library was eluted with 25 μL of 10 mM Tris-Acetate. To the purified library, 5 μL of 10x ExTaq buffer, 4 μL of 2.5 mM dNTPs, 10 pmol each of Primer-3 and Index-1 (see Table 1 above), and 1 μL of ExTaq HS were added. The mixture was then incubated at 72°C for 5 minutes and 95°C for 1 minute, followed by 12 cycles of three incubation steps: 95°C for 15 seconds, 55°C for 15 seconds, and 72°C for 30 seconds, followed by a final incubation at 72°C for 1 minute. The amplified library was loaded onto 2% E-Gel Ex and a gel image was taken. Details of the formation of the V Topo I-oligonucleotide complex (VOC) are as follows.

[0057] <Formation of Vaccinia Virus Topoisomerase I (VTopoi)-Oligonucleotide Complex (VOC)> VTopoi and T4 polynucleotide kinase (T4 PNK) were purified as previously described (Miura F, et al., Scientific Reports, 13, 13913, 2023, supra). Details of ODN (oligodeoxynucleotide; oligo-DNA) for the adapter activated by VTopoi are listed in Table 1. Two types of ODN combinations were used. The first set was a set of PEA1-3C2T-Ext, 1A3G1A-anti-PEA1, and Anti-Ext-1 for non-bisulfite treatment (native), and the second set was a set corresponding to bisulfite treatment of PEA1-1T-3C2T-Ext-met, 1A3G1A-anti-PEA1, and Anti-Ext-1.

[0058] A 1 ml solution containing 10 μM of native or bisulfite ODN set and 1x Oligo Hyb (10 mM Tris-HCl, pH 7.5, 160 mM NaCl) was prepared and incubated at 95°C for 5 minutes, 55°C for 10 minutes, and then held at 30°C. Next, 1 mL of 5x TOPO activation buffer, 500 μL of 1 mg / mL BSA, 100 μL of 100 mM ATP, and 100 μL of 1 mg / mL T4 PNK were added, and the volume was adjusted to 5 mL with water. After equilibrating the reaction solution at 30°C for 10 minutes, 50 nmol of VTopoI was added and further incubated at 30°C for 1 hour. The generated VOCs were purified using a heparin affinity purification column as follows.

[0059] All chromatographic purifications were performed manually using a 5 mL Luer-lock syringe (Terumo, Tokyo, Japan) and a syringe pump (YSP101, YMC, Kyoto, Japan). First, a 1 mL HiTrap Heparin HP column (Cytiva) was equilibrated with 5 mL of Buffer 300. Next, the VTopoI reaction mixture was loaded onto the column, which was then washed with 5 mL of Buffer 300. Finally, VOCs were eluted with 5 mL of Buffer 400. The flow rate was maintained at 2 mL / min. The eluate was then transferred to an Amicon-4 30 kDa device, and buffer exchange and DNA concentration adjustment were performed using Buffer 1000. The final concentration of VOCs was measured using a Qubit dsDNA BR kit (Thermofisher scientific) and adjusted to 150 ng / μL.

[0060] <Specific Contents of this Example> We screened RNA ligases to identify new enzymes with stronger single-stranded DNA ligation activity without adding several adenylate residues (i.e., ribotails) to the 3' end of target single-stranded DNA. First, using TS2126 RNA ligase as a seed, we searched the NCBI (https: / / www.ncbi.nlm.nih.gov / ) amino acid sequence database and identified many homologous proteins. These included T4 RNA ligase (see Non-Patent Documents 10 and 11, cited above), RM378 RNA ligase (see Non-Patent Document 12, cited above), and Mth RNA ligase (see Non-Patent Document 13, cited above) (Figure 1A). Phylogenetic trees drawn using these amino acid sequences revealed that known proteins with single-stranded DNA ligation activity were relatively distant from TS2126 RNA ligase. On the other hand, eight proteins (specifically, eight proteins registered with GenBank accession numbers: AYJ73970, WP_119360902, WP_110532308, WP_126206484, WP_172959156, WP_038069792, WP_081892735, and RTI02525) showed higher homology to TS2126 RNA ligase (Figure 1A). These eight proteins were identified in genome sequencing projects for various purposes, and their single-stranded DNA ligation activity had not been investigated. Therefore, the present inventors investigated the single-stranded DNA ligation activity of these proteins. However, of the eight proteins, two pairs (specifically, the pair WP_172959156 and RTI02525, and the pair WP_081892735 and WP_038069792) had nearly identical amino acid sequences, with only the N-terminal extensions differing in structure (Figure 2). Therefore, of the four proteins associated with these two pairs, only the two with N-terminal extensions (RTI02525 and WP_081892735) were examined.

[0061] First, the genes encoding these enzyme proteins were artificially synthesized and cloned into expression vectors, and the encoded proteins were purified (Figure 3). Next, we confirmed the TACS ligation (with ribotail) and single-stranded DNA ligation activities (without ribotail) of these proteins (Figure 1B). Three of the six proteins were found to exhibit strong TACS ligation activity (Figure 1C). Two of these (AYJ73970 and WP_119360902) exhibited stronger single-stranded DNA ligation activity than TS2126 RNA ligase (Figure 1C). AYJ73970 in particular had superior single-stranded DNA ligation activity (Figure 1C), so we further investigated it. In addition, the enzyme protein of WP_119360902 may also show results and effects similar to or similar to the various results and effects associated with the enzyme protein of AYJ73970 shown below, and is therefore considered to be useful.

[0062] AYJ73970 exhibited single-stranded DNA ligation activity between 20 and 49°C, with an optimum temperature of 37°C (Figure 4). Its single-stranded DNA ligation activity required the presence of polyethylene glycol (PEG) of various molecular weights (Figure 5). The optimum pH range for the reaction solution was 7.5 to 9.5, and activity was confirmed in both Tris- and TAPS-based buffers (Figure 6). AYJ73970 lost activity in the presence of approximately 10 mM ammonium chloride (Figure 7). On the other hand, activity was observed in the presence of 50 mM sodium chloride or potassium chloride, although lower concentrations were preferred (Figure 7). The optimum magnesium concentration was 7.5 to 12.5 mM (Figure 8). Stronger single-stranded DNA ligation activity was observed when the donor and acceptor were 16 or more nucleotides long, and 30 or more nucleotides long, respectively (Figure 9). AYJ73970 showed comparable activity toward both DNA and RNA acceptors, but tended to prefer DNA over RNA as the donor (Figure 10). AYJ73970 could also ligate a single-stranded DNA adapter to double-stranded DNA, but the efficiency was much lower than that of ligating to single-stranded DNA (Figure 11). AYJ73970 was identified in the genome sequence of the bacteriophage Thermus phage phiLo (i.e., this enzyme should be called Tph ssDNA ligase). In this example, this enzyme (AYJ73970) is referred to as "SDL," which is the acronym for single-stranded DNA ligase.

[0063] SDL is the first ligase with strong ligation activity for single-stranded DNA, making it promising for a variety of applications. Therefore, we used SDL in several representative applications. The inventors previously established a protocol for preparing sequencing libraries from single-stranded DNA based on TACS ligation. In this method, to suppress adapter dimer formation, a first adapter is ligated to the target single-stranded DNA, followed by DNA replication starting from the adapter to form double-stranded DNA. Finally, a second adapter ligation reaction is performed using vaccinia virus topoisomerase I (TOPO) (TACS-TOPO method, Figure 12A). This TACS-TOPO method enabled highly sensitive analysis of short single-stranded DNA present in the cell-free fraction of human blood. Furthermore, the TACS-TOPO method improved the yield of library preparation from ancient human bones by more than one order of magnitude. Therefore, a method in which the TACS ligation step in the TACS-TOPO method is replaced with a step using SDL (SDL-TOPO method) was attempted and carried out (FIG. 12).

[0064] The SDL-TOPO method enabled library preparation from single-stranded DNA with efficiency comparable to that of the TACS-TOPO method, but it also demonstrated additional advantages. For example, RNA is sensitive to alkaline conditions, and alkaline desulfonation is an essential step in bisulfite treatment. Therefore, bisulfite treatment could not be applied to sequencing libraries containing ribotails prepared by the TACS-TOPO method. On the other hand, because libraries prepared by the SDL-TOPO method do not contain RNA, bisulfite treatment can be applied to libraries prepared by the SDL-TOPO method. In other words, libraries prepared by the SDL-TOPO method can be used to examine the 5-methylation status of cytosines in their insert DNA (Figure 12). In fact, when a library prepared by the SDL-TOPO method was treated with bisulfite (using Zymo Research's EZ DNA Methylation Gold kit according to the manufacturer's instructions; the same applies below), the resulting reads were almost completely devoid of cytosine, while the distribution of the resulting read lengths did not change with or without bisulfite treatment. These results indicate that the use of SDL-TOPO enables highly sensitive methylome analysis of cell-free DNA in blood (Figure 12).

[0065] SDL has also been shown to be effective for preparing sequencing libraries for genome-wide quantification of DNA methylation levels, known as methylome analysis. The present inventors recently reported the tPBAT method, a library preparation method for whole-genome bisulfite sequencing using TACS ligation (see Non-Patent Document 7, cited above). In the tPBAT method, the first adapter sequence is introduced by random priming using bisulfite-treated DNA as a template. Next, the second adapter is ligated to this first-strand DNA, completing the library preparation. The TACS ligation step in the tPBAT method can also be replaced by SDL (sPBAT method). As a result, the sPBAT method yielded 2-3 times more libraries than the tPBAT method (Figure 13). The quality of the reads obtained with sPBAT was comparable to that of tPBAT, and both methods produced nearly identical results in quantifying DNA methylation levels (Figure 13). Compared to tPBAT, sPBAT has simpler procedures and higher library yields, making it possible to produce more practical and sensitive methylome data ( Figure 13 ). Details of the sPBAT protocol are as described above in the description of Figure 13 (the brief description of the figure). Below, a comparison between tPBAT and sPBAT is described.

[0066] Comparison of tPBAT and sPBAT: 100 nanograms of genomic DNA purified from the IMR-90 cell line (JCRB9054, Japan Research Bioresources Collection Cell Bank) or derived from human female peripheral blood (Promega) was added to 1 ng of unmethylated lambda DNA (Promega) and subjected to bisulfite treatment. tPBAT was performed as previously reported (see Miura F. et al., 2019), and sPBAT was performed using a previously described protocol. Equal molar amounts of tPBAT and sPBAT libraries labeled with different indices were mixed with a PhiX control (Illumina, 20% of the library) and sequenced in 150x2 paired-end mode using a HiSeq X Ten system (Illumina, Tokyo, Japan).

[0067] The applications of SDL are not limited to methylome analysis. For example, SDL can also be used to amplify cDNA. To do this, cDNA is first synthesized using an oligo-dT primer with an amplification adapter sequence ligated to the 5' end. Next, another adapter is ligated to the 3' end of the synthesized cDNA using SDL. In this way, after the SDL reaction, the cDNA has different adapters ligated to both ends, making it possible to amplify it by PCR (Figure 14). In fact, the sequence of the amplified cDNA can be determined using a long-read sequencer. Many reads cover the entire gene, making practical cDNA analysis possible (Figure 14).

[0068] In this example, we identified SDL (AYJ73970) as an enzyme with superior single-stranded DNA ligation activity compared to known enzymes. We also demonstrated its use in preparing four types of sequencing libraries. However, the application of SDL is not limited to the preparation of such libraries. For example, SDL may also be useful for introducing combinatorial indexes. If SDL could be used to ligate a mixture of chemically synthesized DNA with phosphorylated 5' ends to target DNA, it would enable easier index-based cell labeling. SDL is also likely to contribute to the synthesis of artificial gene libraries. SDL is also likely to be suitable for shuffling randomly mixed amino acid codons or specific amino acid sequence modules. SDL may also contribute to the realization of many other applications.

[0069] In addition, the enzyme protein WP_119360902, which has been shown to have stronger single-stranded DNA ligation activity than TS2126 RNA ligase, as well as SDL (AYJ73970), can be used in the same applications as SDL (preparation of four types of sequencing libraries) as described above, and is also thought to be applicable to a variety of other possible applications.

[0070] According to the present invention, it is possible to provide a single-stranded DNA ligation composition as a novel enzyme composition having efficient single-stranded DNA ligation activity, a single-stranded DNA ligation agent, a single-stranded DNA ligation kit, etc. By using the single-stranded DNA ligation composition, etc. of the present invention, single-stranded DNAs serving as donors and acceptors can be ligated without the addition of ribotails, and the single-stranded DNA ligation composition, etc. of the present invention is useful in that it enables, for example, highly efficient preparation of a sequence library.

[0071] SEQ ID NOs: 1, 3, 5-12, 14-16 and 18-31: Synthetic DNA SEQ ID NOs: 13 and 17: Synthetic RNA

Claims

1. A composition for ligating single-stranded DNA, which is used to ligate one or more types of single-stranded DNA as an acceptor and one or more types of single-stranded DNA as a donor, comprising: (a) a protein comprising the amino acid sequence shown in SEQ ID NO: 2 or 4; and / or (b) a protein comprising an amino acid sequence having 70% or more identity to the amino acid sequence shown in SEQ ID NO: 2 or 4 and having single-stranded DNA ligation activity.

2. The composition of claim 1, wherein the acceptor DNA has a base length of 12 or more and / or the donor DNA has a base length of 10 or more.

3. The composition of claim 1, further comprising PEG.

4. A single-stranded DNA linking agent used to link one or more types of single-stranded DNA as an acceptor and one or more types of single-stranded DNA as a donor, the linking agent comprising: (a) a protein comprising the amino acid sequence shown in SEQ ID NO: 2 or 4; and / or (b) a protein comprising an amino acid sequence having 70% or more identity to the amino acid sequence shown in SEQ ID NO: 2 or 4 and having single-stranded DNA linking activity.

5. The linking agent according to claim 4, wherein the acceptor DNA has a base length of 12 or more and / or the donor DNA has a base length of 10 or more.

6. The linking agent of claim 4, further comprising PEG.

7. A single-stranded DNA ligation kit used to ligate one or more types of single-stranded DNA as an acceptor and one or more types of single-stranded DNA as a donor, the kit comprising: (a) a protein comprising the amino acid sequence shown in SEQ ID NO: 2 or 4; and / or (b) a protein comprising an amino acid sequence having 70% or more identity to the amino acid sequence shown in SEQ ID NO: 2 or 4 and having single-stranded DNA ligation activity.

8. The kit according to claim 7, wherein the acceptor DNA has a base length of 12 or more and / or the donor DNA has a base length of 10 or more.

9. The kit of claim 7, further comprising PEG.

10. A method for producing linked single-stranded DNA, comprising contacting one or more types of single-stranded DNA as acceptors and one or more types of single-stranded DNA as donors with (a) a protein comprising the amino acid sequence shown in SEQ ID NO: 2 or 4, and / or (b) a protein comprising an amino acid sequence having 70% or more identity to the amino acid sequence shown in SEQ ID NO: 2 or 4 and having single-stranded DNA ligation activity, thereby linking the acceptor DNA and the donor DNA.

11. A method for linking single-stranded DNAs, comprising contacting one or more types of single-stranded DNA as acceptors and one or more types of single-stranded DNA as donors with (a) a protein comprising the amino acid sequence shown in SEQ ID NO: 2 or 4, and / or (b) a protein comprising an amino acid sequence having 70% or more identity to the amino acid sequence shown in SEQ ID NO: 2 or 4 and having single-stranded DNA linking activity, thereby linking the acceptor DNAs and the donor DNAs.

12. The method according to claim 10 or 11, wherein the acceptor DNA has a base length of 12 or more and / or the donor DNA has a base length of 10 or more.

13. Use of the method according to claim 10 or 11, comprising: (a) a protein comprising the amino acid sequence shown in SEQ ID NO: 2 or 4; and / or (b) a protein comprising an amino acid sequence having 70% or more identity to the amino acid sequence shown in SEQ ID NO: 2 or 4 and having single-stranded DNA ligation activity.

14. A protein for use in the method according to claim 10 or 11, comprising: (a) an amino acid sequence as set forth in SEQ ID NO: 2 or 4; and / or (b) an amino acid sequence having 70% or more identity to the amino acid sequence as set forth in SEQ ID NO: 2 or 4, and having single-stranded DNA ligation activity.

15. A method for preparing a double-stranded DNA library from single-stranded DNA fragments, comprising: (A) a step of ligating a single-stranded adaptor sequence having a phosphorylated 5' end to a target single-stranded DNA fragment; (B) a step of generating double-stranded DNA by performing DNA replication starting from the adaptor of the ligated sequence; (C) a step of ligating a topoisomerase-complexed double-stranded adaptor sequence to the end of the double-stranded DNA to which the adaptor sequence has not been added; and (D) a step of obtaining a library containing a plurality of double-stranded DNAs by PCR using the ligated double-stranded DNA as a template, wherein the ligation in the step (A) is performed by a ligation method using: (a) a protein comprising the amino acid sequence shown in SEQ ID NO: 2 or 4, and / or (b) a protein comprising an amino acid sequence having 70% or more identity to the amino acid sequence shown in SEQ ID NO: 2 or 4 and having single-stranded DNA ligation activity.

16. A method for preparing a double-stranded DNA library from single-stranded DNA fragments, comprising the steps of: (i) ligating a single-stranded adaptor sequence A1 having a phosphorylated 5' end to the 3' end of a single-stranded DNA fragment having dephosphorylated both ends to generate an adaptor-added single-stranded DNA; (ii) annealing a single-stranded adaptor sequence A2 to the adaptor sequence A1 portion contained in the adaptor-added single-stranded DNA, and then extending the 3' end of the adaptor sequence A2 with a DNA polymerase to generate an adaptor-added double-stranded DNA; (iii) reacting a double-stranded adaptor sequence B1, which has only one 5' end phosphorylated and has a topoisomerase recognition sequence in a region including a 3' end complementary to the 5' end, with a topoisomerase to generate a topoisomerase-complexed double-stranded adaptor sequence B2 in which the topoisomerase is conjugated to the 3' end of the recognition sequence; (iv) ligating a topoisomerase-complexed double-stranded adaptor sequence B2 to the end of the adaptor-tagged double-stranded DNA to which no adaptor sequence has been added, to generate a double-stranded DNA with adaptors added at both ends; and (v) obtaining a library containing a plurality of double-stranded DNAs by PCR using the double-stranded DNA with adaptors added at both ends as a template, wherein the ligation and generation in the step (i) is carried out by a ligation method using: (a) a protein comprising the amino acid sequence shown in SEQ ID NO: 2 or 4, and / or (b) a protein comprising an amino acid sequence having 70% or more identity to the amino acid sequence shown in SEQ ID NO: 2 or 4 and having single-stranded DNA ligation activity.

17. A double-stranded DNA library obtained by the preparation method according to claim 15 or 16.